SCHEMBL21875107

SCHEMBL21875107

COc1ccc(S(=O)(=O)n2ccc(C(=O)NCc3cnccn3)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 3/20 0.58
▸ HPGDS O60760 1/20 0.55
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ RAB9A P51151 1/20 0.47
▸ GAA P10253 1/20 0.45
▸ NAMPT P43490 3/20 0.45
▸ TP53 P04637 2/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CYP2C9 P11712 1/20 0.41
▸ MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21875060 0.89 GRM4 (0.47) KLKB1HPGDSKMT2ANAMPTALDH1A1
SCHEMBL21875178 0.87 GRM4 (0.47) KLKB1HPGDSNAMPTALDH1A1KDM4E
SCHEMBL21875134 0.87 ALDH1A1 (0.52) KLKB1HPGDSKMT2ANAMPTALDH1A1
SCHEMBL21875164 0.86 KLKB1 (0.60) KLKB1KMT2AMEN1NAMPTTP53
SCHEMBL21875152 0.84 KLKB1 (0.60) KLKB1KMT2AMEN1NAMPTTP53
SCHEMBL21875082 0.82 KLKB1 (0.58) KLKB1KMT2AMEN1NAMPTTP53
SCHEMBL21875147 0.82 KLKB1 (0.62) KLKB1TP53ALDH1A1KDM4ECYP1A2
SCHEMBL21875099 0.82 KLKB1 (0.59) KLKB1HPGDSKMT2AMEN1NAMPT
SCHEMBL21875111 0.81 KLKB1 (0.57) KLKB1KMT2ANAMPTTP53MAPT
SCHEMBL22588439 0.81 RAB9A (0.52) KLKB1HPGDSKMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN claimed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US claimed
CN-113056461-A Arylsulfonyl pyrrole carboxamide derivatives as Kv3 potassium channel activators H.隆德贝克有限公司 2021-06-29 — — CN disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS H. LUNDBECK A/S (DK) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131156-A1 ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS KCNA3, KCNN3, KCNK3 KLKB1 784/4885HPGDS 4079/4885KMT2A 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback